Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

Fig. 2

Effect of telmisartan on systolic blood pressure, heart rate and serum levels of cardiac enzymes in diet-induced obesity hypertension. a Systolic blood pressure in control, DIO and DIO + Tel groups. b Heart rate in control, DIO and DIO + Tel groups. c Serum lactate dehydrogenase level in control, DIO and DIO + Tel groups. d Serum cardiac troponin I level in control, DIO and DIO + Tel groups (number of rats = 10/group. P < 0.05 considered significant, * significant when compared to the control group, • significant when compared to the DIO group)

Back to article page